Biotechnology Companies By Roe

Return On Equity
ROEEfficiencyMarket RiskExp Return
1ROIV Roivant Sciences
1.29
 0.08 
 1.69 
 0.14 
2HALO Halozyme Therapeutics
1.12
(0.08)
 3.80 
(0.31)
3MDXG MiMedx Group
0.62
 0.16 
 4.27 
 0.67 
4MEIP MEI Pharma
0.62
(0.05)
 2.51 
(0.14)
5ABBV AbbVie Inc
0.56
(0.04)
 2.09 
(0.09)
6AMGN Amgen Inc
0.56
(0.13)
 1.69 
(0.22)
7AGIO Agios Pharm
0.54
 0.17 
 2.95 
 0.49 
8PMCB PharmaCyte Biotech
0.48
 0.07 
 5.25 
 0.38 
9PBYI Puma Biotechnology
0.42
 0.13 
 4.32 
 0.58 
10PTGX Protagonist Therapeutics
0.41
 0.05 
 2.78 
 0.13 
11PROC Procaps Group SA
0.37
 0.05 
 17.06 
 0.78 
12PROCW Procaps Group SA
0.37
 0.04 
 16.77 
 0.68 
13ADMA ADMA Biologics
0.36
 0.09 
 4.82 
 0.42 
14ALKS Alkermes Plc
0.29
 0.03 
 2.37 
 0.08 
15CPRX Catalyst Pharmaceuticals
0.28
 0.10 
 1.91 
 0.20 
16ACAD ACADIA Pharmaceuticals
0.27
 0.01 
 2.24 
 0.02 
17GNFT Genfit
0.26
 0.03 
 4.40 
 0.14 
18SPRO Spero Therapeutics
0.26
(0.09)
 2.53 
(0.22)
19DTIL Precision BioSciences
0.24
(0.16)
 3.14 
(0.51)
20XFOR X4 Pharmaceuticals
0.22
(0.02)
 10.16 
(0.23)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.